Breast Cancer Foundation NZ
Role of MRI in evaluating patients with lobular breast cancer
February 2015
Research Grant
What is the problem and who is affected?
Magnetic resonance imaging (MRI) is a routine, albeit expensive, test used in lobular breast cancer. Unfortunately, the high cost means that some DHBs struggle to meet the MRI demand. Some doctors also suspect that it may not make a difference to patient outcomes in lobular breast cancer.
What is this research hoping to achieve?
Dr Kwok and his team will evaluate the efficacy of MRI as a diagnostic tool for patients with lobular breast cancer. The study will compare the accuracy of MRI against other cancer staging tests. They will also evaluate the impact of use of MRI on long term outcomes for patients.
-
MarchResearch Grant
First clinical evaluation of laser treatment for lymphoedema in New Zealand
-
FebruaryResearch Grant
An investigation into the impact of radiation treatment on Triple Negative Breast Cancer
-
FebruaryResearch Grant
Role of MRI in evaluating patients with lobular breast cancer
-
FebruaryResearch Grant
Expanding the breast cancer register